Small Biotechs; Big Decisions

Norstella
Norstella

A limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation. View the video series and find out more information here: www.citeline.com/biotech

Folgen

  1. 11.06.2025

    How to Survive Innovation Pressure in Today’s Biotech Landscape

    Small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resilience are rising. This episode explores how biotechs ignite innovation despite economic headwinds, regulatory uncertainty, and fierce competition. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech

    How to Survive Innovation Pressure in Today’s Biotech Landscape

  2. 11.06.2025

    Strategies to Secure Critical Biotech Funding Amid Market Challenges

    Biotechs are racing to change the rules in this tough market. This episode reveals how AI, real-world data, and strategic partnerships are reshaping drug development. Is reinvention biotech’s last hope? Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech

    Strategies to Secure Critical Biotech Funding Amid Market Challenges

  3. 23.06.2025

    How to Crush Competitive Threats and Stand Out in Biotech

    The race for new therapies is more intense than ever. This episode uncovers how biotech and pharma use competitive intelligence, AI, and data to outsmart rivals and change the game. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech

    How to Crush Competitive Threats and Stand Out in Biotech

  4. 30.06.2025

    Master Regulatory Hurdles and Accelerate Your Drug Development

    With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing real-world data, and finding new global pathways to bring therapies to life. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech

    Master Regulatory Hurdles and Accelerate Your Drug Development

  5. 12.09.2025

    Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech

    What makes a biotech-CRO partnership truly work? Claire Riches, VP, Clinical Solutions, Citeline, and Matt Simmons, Senior Director, Oncology Strategy, IQVIA Biotech, share the secrets behind winning biotech-CRO partnerships, covering collaboration, transparent budgeting, regulatory navigation, and recruitment strategies, with essential insights to help biotechs succeed from their first RFP to global trials. View the video series and find out more information here: https://www.citeline.com/biotech

    Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech

  6. 22.10.2025

    Winning Biotech Investors Through Strategic Partnerships and Trial Innovation

    Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CEO of Worldwide Clinical Trials as they reveal insider strategies for securing investors, navigating partnerships, and turning innovative science into real-world success. View the video series and find out more information here: https://www.citeline.com/biotech

    Winning Biotech Investors Through Strategic Partnerships and Trial Innovation

  7. 25. Mai

    Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design

    "Biotechs are running increasingly complex clinical trials with lean teams, tight budgets, and growing pressure to deliver faster results. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus to explore how smarter outsourcing, stronger CRO partnerships, and patient‑focused trial design can improve execution, control costs, and reduce operational risk, while avoiding unnecessary burden on sites and participants. View the video series and find out more information here: https://www.citeline.com/biotech"

    Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design

  8. 26. Juni

    Elevate Clinical Operations into a Board Level Strategic Advantage

    Clinical operations plays a decisive role in execution quality, data integrity, cost control, and development speed, yet it is often treated as a cost centre rather than a strategic function. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Executive Consultant, Clinical Development Operations to discuss why clinical operations must be elevated into board‑level conversations. Together, they explore how clinops drives value, manages risk, and shapes long‑term development strategy, and what boards and executives need to understand to make better, more informed decisions. View the video series and find out more information here: https://www.citeline.com/biotech

    Elevate Clinical Operations into a Board Level Strategic Advantage
  • 8 Folgen

Info

A limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation. View the video series and find out more information here: www.citeline.com/biotech

Informationen

Mehr von Norstella